Response to Mitr and Pollack
J Natl Cancer Inst
.
2022 Dec 8;114(12):1729-1730.
doi: 10.1093/jnci/djac133.
Authors
Daniel P Wickland
1
,
Mark E Sherman
1
,
Derek C Radisky
2
,
Aaron S Mansfield
3
4
,
Yan W Asmann
1
4
Affiliations
1
Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
2
Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
3
Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
4
Precision Cancer Therapeutics, Mayo Clinic Center for Individualized Medicine, Rochester, MN, USA.
PMID:
35801929
PMCID:
PMC9745428
DOI:
10.1093/jnci/djac133
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
Grants and funding
R01 CA237602/CA/NCI NIH HHS/United States